We are committed to provide our readers with leading information on all aspects of MS, NMO and related autoimmune diseases of the central nervous system.
#MultipleSclerosis therapies in women are associated with increased risks of HPV positivity, cervical dysplasia/cancer, cervicitis, herpes simplex virus, vulvovaginitis, and Bartholin cysts/abscess.
Study from @harvardmed@UCSF ▶️ journals.sagepub.com/doi/10.…
A 35-year-old woman with relapsing #MultipleSclerosis continued ofatumumab until 28 weeks of gestation and resumed maintenance therapy postpartum without re-induction. Her infant showed normal B cells and completed vaccinations.
🔓 MSJ-ETC case report ▶️ journals.sagepub.com/doi/10.…
A 31-year-old male with #MultipleSclerosis on ofatumumab who had a bat fly into his hand, needed the standard rabies vaccination series and two additional booster vaccinations, to establish humoral.
🔓MSJ-ETC case report from @UTSWMedCenter ▶️ journals.sagepub.com/doi/10.…
🎥 Why are fellowships at the heart of ECTRIMS activities?
In this short video, Prof. Gabriel Bsteh from the Medizinische Universität Wien highlights how @ECTRIMS Fellowships empower young researchers and clinicians to access opportunities they might not have at home — from advanced education to cutting-edge scientific and clinical training.
Fellowships are more than just time abroad. They create lasting bonds: most fellows remain active contributors to the ECTRIMS community long after their fellowship ends.
📅 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 1 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫 2026
▶️ 𝐀𝐩𝐩𝐥𝐲 𝐯𝐢𝐚 𝐦𝐲𝐄𝐂𝐓𝐑𝐈𝐌𝐒: bit.ly/3ZBesDZ#MSResearch#Fellowships#ECTRIMSNextGen
And commentary from @DalhousieU@UTAS_: We must fully understand what factors (age, family history, perceived severity or treatability) would influence decision-making, and demonstrate secondary prevention of #MultipleSclerosis.
🔽
journals.sagepub.com/doi/ful…
4/🧵
In multiple sclerosis, starting kesimpta shortly after stopping tysabri is effective in preventing post-tysabri rebound disease activity according to this case series of 61 people with MS (mean follow up 2.4 years; no relapses or MRI activity) journals.sagepub.com/doi/10.…